Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc. (MIRM) Stock Overview
Explore Mirum Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
4.6B
P/E Ratio
-196.77
EPS (TTM)
$-0.47
ROE
-0.09%
MIRM Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Mirum Pharmaceuticals, Inc. (MIRM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 43.56, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $119.58.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -196.77 and a market capitalization of 4.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.